$VBIV News Article - VBI Vaccines Announces Publication of Results from Pivotal Phase 3 Study, PROTECT, of VBI's Prophylactic 3-Antigen Hepatitis B Vaccine Candidate in The Lancet Infectious Diseases https://marketwirenews.com/news-releases/vbi-...61509.html
My Twitter: WhyteStocks